Do gender differences in CD4 cell counts matter?

AIDS

Volumn 13, Issue 17, 1999, Pages 2361-2364

  Prins, Maria ^a,b   Roy Robertson, J ^b,c,d,e   Brettle, Raymond P ^e,g,h   Aguado, Ildefonso Hernández ^c,e,g   Broers, Barbara ^c,d,f   Boufassa, Faroudy ^e,f,g   Goldberg, David J ^a,b,c   Zangerle, Robert ^a,d,g   Coutinho, Roel A ^a   Van Hoek, Anneke Den ^h  

^a MUNICIPAL HEALTH SERVICE   (Netherlands)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^e BICÊTRE HOSPITAL   (France)

^f RUCHILL HOSPITAL   (United Kingdom)

^g UNIVERSITY OF INNSBRUCK   (Austria)

^h UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

CD4 cell counts; Gender differences; Treatment guidelines

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CAUSE OF DEATH; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEROCONVERSION; SEX DIFFERENCE;

EID: 0032793898     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199912030-00007     Document Type: Article

References (18)

1. Tollerud DJ, Clark JW, Morris Brown L, et al. The influence of age, race, and gender on peripheral blood mononuclear-cell subsets in healthy nonsmokers. J Clin Immunol 1989, 9:214-222.
2. Maini MK, Cilson RJC, Chavda N, et al. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Cenitourln Med 1996, 72:27-31.
3. 2-microglobulin are not adequate to estimate time of HIV infection. AIDS 1994, 8:923-933.
4. Delmas MC, Jadand C, de Vincenzi I, et al. Gender differences in CD4 cell counts persist after HIV-1 infection. AIDS 1997, 11:1071-1073.
5. Rezza G, D'Egidio P, Cozzi Lepri A, Costantini D, Petrucci A, Pezzotti P. Effects of age, gender, duration of drug use and infection with viral hepatitis B and C on lymphocyte subsets in a population of HIV-negative drug users in Italy. Addict Biol 1997,2:201-206.
6. Reichert T, de Bruyère M, Deneys V, et al. Lymphocyte subset reference ranges in adult Caucasians. Clin Immunol Immunopalhol 1991, 60:190-208.
7. Ronald PJM, Robertson JR, Elton RA. Continued drug use and other cofactors for progression to AIDS among injecting drug users. AIDS 1994, 8:339-343.
8. Cozzi Lepri A, Pezzotti P, Dorrucci M, Phillips AN, Rezza C. The Italian Seroconversion Study. HIV disease progression in 854 women and men infected through injecting drug use and heterosexual sex and followed for up to nine years from seroconversion. BMJ 1994, 309:1537-1542.
9. Brettle RP, McNeil AJ, Burns S, et al. Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS 1996, 10:419-430.
10. Phillips AN, Antunes F, Stergious G, et al. A sex comparison of rates of new AIDS defining disease and death in 2554 AIDS cases. AIDS 1994, 8:831-835.
11. Prins M, Veugelers PJ for the European Seroconverter Study and the Tricontinental Seroconverter Study. Comparison of progression and nonprogression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. AIDS1997, 11:621-631.
12. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome MMIVR 1987, 36:1 S-15S.
13. SAS Institute I. SAS/STAT Software: Changes and Enhancements through Release 6.11. SAS Institute; Cary, North Carolina 27513 1996.
14. Krol A, Flynn C, Vlahov D, et al. New evidence to reconcile in vitro and epidemiologic data on the possible role of heroin on CD4 decline among HIV-infected injecting drug users. Drug Alcohol Depend 1999, 54:145-154.
15. Prins M, Brettle RP, Robertson JR, et aJ. Geographic variation in disease progression in HIV-1 seroconverted injecting drug users in Europe? Int J Epidemiol, 1999, 28:541-549.
16. Evans JS, Nims T, Cooley J, et al. Serum levels of virus burden in early-stage human immunodeficiency virus type 1 disease in womenj Infect Dis 1997, 175:795-800.
17. Sterling T, Lyles C, Quinn TC, et al. Gender-specific differences in HIV-1 RNA level in a longitudinal study of HIV-1 seroconverters. Xllth International Conference on AIDS, Geneva, June 1998 (abstract 13379).
18. Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HIV-1 viral load and progression to AIDS. lancet 1998, 352:1510-1514.